Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Financial Advisers Advised to Adopt Evidence Based Approach

Financial Advisers Advised to Adopt an Evidence Based Approach

The Financial Markets Authority has sent a strong message to New Zealand’s investment advisory community: poor advice practices and unsubstantiated advice will not be tolerated.

Guests at a private function in Auckland this evening gained valuable insights into the unique approach one New Zealand firm is taking to help advisers deliver high quality investment advice.

The event, hosted by Consilium NZ Ltd, was attended by some of the sector’s leading advisers and proponents for increased responsibility among financial advisers.

Previously known as NZ Wealth Adviser Services, Consilium NZ Ltd is spearheading the move towards independent, evidence based investment advice.

Consilium’s carefully engineered diversified investment models provide investors with low cost access to proven sources of higher long term expected returns. Consilium, on behalf of their partner firms, manage close to $1billion NZD.

“Our approach is built on the premise that risk is the basis of return. Differences in average portfolio returns can be explained by differences in risk. Portfolio management becomes an issue of asset allocation across the dimensions of risk, rather than an issue of perceived money manager merit,” says Scott Alman, Managing Director of Consilium.

Consilium’s investment solution is audited annually to meet the requirements of the Centre for Fiduciary Excellence (CEFEX), which establishes global best practice standards for investment selection, monitoring and reporting.

“There is overwhelming evidence that most investment strategies based on forecasting and market timing fail to add sufficient return to justify the additional cost. From a risk adjusted return perspective, evidence based strategies typically provide a more rewarding investment experience,” says newly appointed member of Consilium’s investment committee, Dr Bart Frijns. Dr Frijns is a Professor of Finance at Auckland University of Technology and Director of the Auckland Centre for Financial Research.

As the only New Zealand company certified for support services by CEFEX, Consilium provides critical investment and adviser support to the New Zealand investment community.

Consilium’s clients include independent Authorised Financial Advisers, financial institutions and not-for-profit organisations charged with the responsibility of protecting and growing the financial assets of their clients.

Ends.

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news